Bilaketaren emaitzak - Timothy Devos

Findu emaitzak
  1. 1
    CXCL8 and its cognate receptors CXCR1/CXCR2 in primary myelofibrosis

    CXCL8 and its cognate receptors CXCR1/CXCR2 in primary myelofibrosis nork Gaël Vermeersch, Paul Proost, Sofie Struyf, Mieke Gouwy, Timothy Devos

    Argitaratua 2024
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Machine perfusion in organ transplantation

    Machine perfusion in organ transplantation nork Dirk Van Raemdonck, Arne Neyrinck, Filip Rega, Timothy Devos, Jacques Pirenne

    Argitaratua 2012
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Diagnosis and management of PNH: Review and recommendations from a Belgian expert panel

    Diagnosis and management of PNH: Review and recommendations from a Belgian expert panel nork Timothy Devos, Stef Meers, Nancy Boeckx, André Gothot, Dries Deeren, Bernard Châtelain, C Chatelain, Bérangère Devalet

    Argitaratua 2018
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Myeloablative Conditioning Predisposes Patients for<i>Toxoplasma gondii</i>Reactivation after Allogeneic Stem Cell Transplantation

    Myeloablative Conditioning Predisposes Patients for<i>Toxoplasma gondii</i>Reactivation after Allogeneic Stem Cell Transplantation nork Stef Meers, Katrien Lagrou, Koen Theunissen, Daan Dierickx, Michel Delforge, Timothy Devos, Ann Janssens, Wouter Meersseman, Gregor Verhoef, Johan Van Eldere, Johan Maertens

    Argitaratua 2010
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Ruxolitinib versus best available therapy in inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): 5-year follow up of a randomised, phase 3b study

    Ruxolitinib versus best available therapy in inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): 5-year follow up of a randomised, phase 3b study nork Francesco Passamonti, Francesca Palandri, Güray Saydam, Jeannie Callum, Timothy Devos, Paola Guglielmelli, Alessandro M. Vannucchi, Evren Zor, Mike W. Zuurman, Geralyn Gilotti, Yifan Zhang, Martin Grießhammer

    Argitaratua 2022
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Single and Multiple Dose MultiStem (Multipotent Adult Progenitor Cell) Therapy Prophylaxis of Acute Graft-versus-Host Disease in Myeloablative Allogeneic Hematopoietic Cell Transplantation: A Phase 1 Trial

    Single and Multiple Dose MultiStem (Multipotent Adult Progenitor Cell) Therapy Prophylaxis of Acute Graft-versus-Host Disease in Myeloablative Allogeneic Hematopoietic Cell Transpl... nork Richard T. Maziarz, Timothy Devos, Carlos Bachier, Steven C. Goldstein, José F. Leis, Steven M. Devine, Gabrielle Meyers, James Gajewski, Johan Maertens, Robert Deans, Wouter van’t Hof, Hillard M. Lazarus

    Argitaratua 2014
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Ruxolitinib for the treatment of inadequately controlled polycythemia vera without splenomegaly: 80-week follow-up from the RESPONSE-2 trial

    Ruxolitinib for the treatment of inadequately controlled polycythemia vera without splenomegaly: 80-week follow-up from the RESPONSE-2 trial nork Martin Grießhammer, Güray Saydam, Francesca Palandri, Giulia Benevolo, Miklós Egyed, Jeannie Callum, Timothy Devos, Serdar Şıvgın, Paola Guglielmelli, Caroline Bensasson, Md Mahmudul Hasan Khan, Julian Perez Ronco, Francesco Passamonti

    Argitaratua 2018
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Analysis of phenotype and outcome in essential thrombocythemia with CALR or JAK2 mutations

    Analysis of phenotype and outcome in essential thrombocythemia with CALR or JAK2 mutations nork Carla Al Assaf, Florence Van Obbergh, Johan Billiet, Els Lierman, Timothy Devos, Carlos Graux, Anne-Sophie Hervent, Jan Emmerechts, Thomas Tousseyn, Pascale De Paepe, Petros Papadopoulos, Lucienne Michaux, Peter Vandenberghe

    Argitaratua 2015
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  9. 9
    SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor–Naïve Patients With Myelofibrosis

    SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor–Naïve Patients With Myelofibrosis nork Ruben A. Mesa, Jean‐Jacques Kiladjian, John Catalano, Timothy Devos, Miklós Egyed, Andrzei Hellmann, Donal P. McLornan, Kazuya Shimoda, Elliott F. Winton, Wei Deng, Ronald L. Dubowy, Julia D. Maltzman, Francisco Cervantes, Jason Gotlib

    Argitaratua 2017
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence

    A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence nork Ayalew Tefferi, Haifa Kathrin Al‐Ali, Giovanni Barosi, Timothy Devos, Heinz Gisslinger, Qingwu Jiang, Jean‐Jacques Kiladjian, Ruben A. Mesa, Francesco Passamonti, Vincent Ribrag, Gary J. Schiller, Alessandro M. Vannucchi, D Zhou, D Reiser, Judy Zhong, Gale Rp

    Argitaratua 2016
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Convalescent plasma treatment of persistent severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) infection in patients with lymphoma with impaired humoral immunity and lack of neutralising antibodies

    Convalescent plasma treatment of persistent severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) infection in patients with lymphoma with impaired humoral immunity and lack... nork Albrecht Betrains, Laurent Godinas, F. J. Sherida H. Woei‐A‐Jin, Wouter Rosseels, Yannick Van Herck, Natalie Lorent, Daan Dierickx, Veerle Compernolle, Geert Meyfroidt, Lore Vanderbeke, Valentijn Vergote, Katrien Lagrou, Peter Verhamme, Joost Wauters, Pieter Vermeersch, Timothy Devos, Piet Maes, Steven Vanderschueren

    Argitaratua 2020
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Overall survival in the SIMPLIFY-1 and SIMPLIFY-2 phase 3 trials of momelotinib in patients with myelofibrosis

    Overall survival in the SIMPLIFY-1 and SIMPLIFY-2 phase 3 trials of momelotinib in patients with myelofibrosis nork Ruben A. Mesa, Claire Harrison, Stephen T. Oh, Aaron T. Gerds, Vikas Gupta, John Catalano, Francisco Cervantes, Timothy Devos, Marek Hus, Jean‐Jacques Kiladjian, Ewa Lech‐Marańda, Donal P. McLornan, Alessandro M. Vannucchi, Uwe Platzbecker, Mei Huang, Bryan Strouse, Barbara Klencke, Srđan Verstovšek

    Argitaratua 2022
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis

    Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis nork Stephen T. Oh, Srđan Verstovšek, Vikas Gupta, Uwe Platzbecker, Timothy Devos, Jean‐Jacques Kiladjian, Donal P. McLornan, Andrew C. Perkins, María Laura Fox, Mary Frances McMullin, Adam J. Mead, Miklós Egyed, Jiří Mayer, Tomasz Sacha, Jun Kawashima, Mei Huang, Bryan Strouse, Ruben A. Mesa

    Argitaratua 2024
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  14. 14
    KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia

    KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia nork Roel Willemze, Celso Arrais‐Rodrigues, Myriam Labopin, Guillermo Sanz, Gérard Michel, Gèrard Socié, Bernard Rio, Anne Sîrvent, M. Renaud, Luís Madero, Mohamad Mohty, Christelle Ferrà, Federico Garnier, Philippe M. Loiseau, Juan Carlos García‐Ruiz, Lucilla Lecchi, G. Kögler, Yves Béguin, Cristina Navarrete, Timothy Devos, Irina Ionescu, Karim Boudjedir, A-L Herr, Éliane Gluckman, Vanderson Rocha

    Argitaratua 2009
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis

    A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis nork Francesco Passamonti, Toni Giorgino, Barbara Mora, Paola Guglielmelli, Elisa Rumi, Margherita Maffioli, Alessandro Rambaldi, Marianna Caramella, Rami S. Komrokji, Jason Gotlib, Jean‐Jacques Kiladjian, Francisco Cervantes, Timothy Devos, Francesca Palandri, Valerio De Stefano, Marco Ruggeri, Richard T. Silver, Giulia Benevolo, Francesco Albano, Domenica Caramazza, Michele Merli, Daniela Pietra, Rosario Casalone, Giada Rotunno, Tiziano Barbui, Mario Cazzola, Alessandro M. Vannucchi

    Argitaratua 2017
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma

    Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma nork Timothy Devos, Quentin Van Thillo, Veerle Compernolle, Tomé Najdovski, Márta Romano, Nicolás Dauby, Laurent Jadot, Mathias Leys, Evelyne Maillart, Sarah Loof, Lucie Seyler, Martial Moonen, Michel Moutschen, Niels Van Regenmortel, Kevin K. Ariën, Cyril Barbezange, Albrecht Betrains, Mutien‐Marie Garigliany, Matthias M. Engelen, Iwein Gyselinck, Piet Maes, Alexander Schauwvlieghe, Laurens Liesenborghs, Ann Belmans, Peter Verhamme, Geert Meyfroidt

    Argitaratua 2021
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  17. 17
    MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis

    MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis nork John Mascarenhas, Marina Kremyanskaya, Andrea Patriarca, Francesca Palandri, Timothy Devos, Francesco Passamonti, Raajit K. Rampal, Adam J. Mead, Gabriella Hobbs, Joseph M. Scandura, Moshe Talpaz, Nikki Granacher, Tim C. P. Somervaille, Ronald Hoffman, Mariëlle J. Wondergem, Mohamed E. Salama, Gozde Colak, Jike Cui, Jean‐Jacques Kiladjian, Alessandro M. Vannucchi, Srđan Verstovšek, Natalia Curto‐García, Claire Harrison, Vikas Gupta

    Argitaratua 2023
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  18. 18
    Transform-1: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, International Phase 3 Study of Navitoclax in Combination with Ruxolitinib Versus Ruxolitinib Plus Placebo in Patients with Untreated Myelofibrosis

    Transform-1: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, International Phase 3 Study of Navitoclax in Combination with Ruxolitinib Versus Ruxolitinib Plus Placebo... nork Naveen Pemmaraju, Adam J. Mead, Tim C. P. Somervaille, James McCloskey, Francesca Palandri, Steffen Koschmieder, David Lavie, Brian Leber, Su‐Peng Yeh, María Teresa Gómez‐Casares, Emanuele Ammatuna, Ho‐Jin Shin, Keita Kirito, Éric Jourdan, Timothy Devos, Hun Chuah, Atanas Radinoff, Andrija Bogdanović, Rastislav Moskal, Qi Jiang, Avijeet Chopra, Elektra J. Papadopoulos, Jalaja Potluri, Francesco Passamonti

    Argitaratua 2023
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  19. 19
    Phase III MANIFEST-2: Pelabresib + Ruxolitinib vs Placebo + Ruxolitinib in JAK Inhibitor Treatment-Naive Myelofibrosis

    Phase III MANIFEST-2: Pelabresib + Ruxolitinib vs Placebo + Ruxolitinib in JAK Inhibitor Treatment-Naive Myelofibrosis nork Claire Harrison, Vikas Gupta, Aaron T. Gerds, Raajit K. Rampal, Srđan Verstovšek, Moshe Talpaz, Jean‐Jacques Kiladjian, Ruben A. Mesa, Andrew Kuykendall, Alessandro M. Vannucchi, Francesca Palandri, Sebastian Grosicki, Timothy Devos, Éric Jourdan, Mariëlle J. Wondergem, Haifa Kathrin Al‐Ali, Veronika Buxhofer‐Ausch, Alberto Álvarez‐Larrán, Andrea Patriarca, Marina Kremyanskaya, Adam J. Mead, Sanjay Akhani, Yuri Sheikine, Gozde Colak, John Mascarenhas

    Argitaratua 2022
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    Association of Convalescent Plasma Treatment With Clinical Status in Patients Hospitalized With COVID-19

    Association of Convalescent Plasma Treatment With Clinical Status in Patients Hospitalized With COVID-19 nork Andrea B. Troxel, Eva Petkova, Keith Goldfeld, Mengling Liu, Thaddeus Tarpey, Yinxiang Wu, Danni Wu, Anup Agarwal, C. Avendaño, Emma Bainbridge, Katherine J. Bar, Timothy Devos, Rafael F. Duarte, Arvind Gharbharan, Priscilla Y. Hsue, Deepak Kumar, Annie Luetkemeyer, Geert Meyfroidt, André Moraes Nicola, Aparna Mukherjee, Mila B. Ortigoza, Liise-anne Pirofski, Bart Rijnders, Casper Rokx, Arantxa Sancho-López, Pamela A. Shaw, Pablo Tebas, Hyunah Yoon, Corita R. Grudzen, Judith S. Hochman, Elliott M. Antman

    Argitaratua 2022
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: